Headquartered in Philadelphia, PA Fiscal year ends March NASDAQ: HLNE hamiltonlane.com
Hamilton Lane Incorporated (Nasdaq: HLNE) is a private markets investment firm dedicated exclusively to private markets for more than 35 years. It serves institutional and private wealth investors globally and had approximately 1.1 trillion dollars in assets under management and supervision as of September 30, 2026: about 150.8 billion dollars discretionary (AUM) and 929.1 billion dollars non-discretionary (AUA).
Its revenue comes primarily from recurring management and advisory fees across several lines:
- Specialized funds, including secondary, direct equity/co-investment, direct credit, infrastructure, impact, venture capital and evergreen vehicles.
- Customized separate accounts built for large institutional clients.
- Advisory services.
- Reporting, monitoring, data and analytics.
- Distribution management.
- Fund reimbursement.
It also earns incentive fees and carried interest, with roughly 1.6 billion dollars of unrealized carry. The firm employs approximately 820 professionals across North America, Europe, Asia Pacific and the Middle East. Hamilton Lane Incorporated is a holding company whose sole material asset is its interest in operating entity Hamilton Lane Advisors, L.L.C. Updated
Fee-related earnings margin expanded to 51%, so the revenue miss on carried interest is a timing matter, not a破 in the recurring base. EPS beat expectations and management is targeting a $2.40 full-year dividend.
Broadcom is sending shareholders about $3.1 billion, at 65 cents a share, with the money arriving September 30. Meta adds another $1.16 billion, and Lamar Advertising, Hamilton Lane and Stock Yards Bancorp round out the day's biggest payers.
Hamilton Lane just bumped its dividend for the ninth consecutive year, but a 32% stock selloff and management's own warning about uneven growth raise a pointed question: does the income hold up…
Hamilton Lane Incorporated (Nasdaq: HLNE) is a private markets investment firm dedicated exclusively to private markets for more than 35 years.
24/7 Wall St.'s 12-month price target for HLNE is $114.64, rated Buy. The Wall Street consensus target is $123.12. HLNE price prediction →
